Morning Report | Israel-Iran strikes lift crude, inflation hedges back in play
$USO crude pops on Hormuz risk $TLT bonds slide, Fed-cut doubts $SMH semis hit, crowded unwind $QQQ megacaps softer, rate fears $LLY retatrutide data lifts obesity trade
Market Pulse
AI
5 events
Semis and AI complex face a crowded-position unwind as higher-for-longer fears and a Broadcom miss collide with fresh policy noise.
Latest Development
Risk-off deepened across Asia and Europe as Korea’s Kospi closed -8.3% after an early halt, with Samsung -10.2% and SK Hynix -7.7%; Taiwan’s Taiex finished -3.5%.
Financial Times reported the White House is discussing a Public Wealth Fund concept where frontier AI labs would contribute small equity stakes, likely voluntarily, but any mandatory structure would face congressional and legal hurdles.
Friday’s semiconductor momentum broke as SMH hit nearly -10% intraday and VIX posted its biggest jump since March; Cboe reported a record 7.8m S&P 500 options contracts, +16% versus the prior record.
OpenAI is preparing its largest ChatGPT redesign since 2022 to push agents and Codex in a “superapp” model, with rollout expected in coming weeks and business customers cited at ~2m and ~40% of revenue.
AIFA said it is accelerating planning, policy coordination, and financing arrangements for a proposed Hainan silicon-photonics supercomputing center and digital industrial park, while approvals remain pending for its HyalRoute control acquisition.
Market reaction
Selling pressure was explicit: Nasdaq fell 4.2% Friday and the S&P 500 dropped 2.6%, while SMH lost more than 9% and VIX jumped sharply amid record S&P 500 options volume. Monday index futures were modestly higher (Nasdaq 100 +0.7%, S&P +0.3%), signaling continued volatility rather than a clean reversal.
Our view
AI/semis trade stays risk-off and volatile near term as positioning resets alongside rate repricing. Stabilization likely requires calmer rates after the jobs-driven 10-year swing and evidence the Broadcom-led earnings shock is contained, with index futures follow-through replacing headline-driven whipsaws.
What could change our view
Rates reprice lower quickly, compressing vol and triggering a fast semiconductor rebound.
Public Wealth Fund idea shifts from voluntary to mandated equity contributions.
Tickers: $SMH, $QQQ, $MSFT, $AIFA
Mideast War
4 events
Israel-Iran strikes hit energy and air defenses as Lebanon and Hormuz risks linger, pushing crude higher and keeping inflation hedges in focus.
Latest Development
Israel said it struck Iran’s Mahshahr petrochemical complex and multiple military air-defense targets; Iran reported damage and evacuations, then launched missiles at northern Israel and claimed a retaliatory petrochemical strike in Haifa.
Israel carried out airstrikes on Beirut’s southern outskirts after rockets were fired toward northern Israel, described as the first such Beirut-area strike since a U.S.-announced Lebanon truce plan last week.
U.S. forces counted nearly 1,000 commercial transits through the Strait of Hormuz over roughly two months, with reporting citing AIS shutoffs, alternate routing near Oman, and an IRGC-controlled lane with tolls and enforcement.
A source said Treasury Secretary Scott Bessent directed collection of Gulf repair-cost estimates and is exploring using Iranian assets to fund rebuilding tied to Iran-war damage, with legal authorities, asset pools, and timelines unspecified.
Market reaction
Brent traded about $97.14–$97.58/bbl (+4% to +5% on the session) and WTI about $94.39–$94.70 (+4% to +5%); U.S. 2-year yields briefly touched ~4.2%.
Our view
Geopolitics keeps a near-term risk premium in crude while physical flows through Hormuz stay constrained but functioning under heightened security. Monitor whether additional strikes extend to energy infrastructure or whether the Lebanon framework deteriorates, which would raise the probability of broader disruption.
What could change our view
Sustained attacks on Gulf energy sites or tankers trigger material supply outages.
Rapid de-escalation restores April ceasefire credibility and compresses oil risk premium.
Tickers: $USO, $CL=F
Biopharma
4 events
Obesity drug data dominated biopharma tape as Zealand sank on GI tolerability, while Lilly touted retatrutide comorbidity benefits and Sanofi gained EU convenience approval.
Latest Development
Zealand’s full Phase III survodutide readout met key targets but showed 19% GI-driven discontinuations versus 2.9% placebo, with Barclays citing over 40% vomiting in the dataset.
At ADA, Lilly presented Phase 3 results where weekly retatrutide cut moderate-to-severe sleep apnea severity 60.6% and reduced knee osteoarthritis pain up to 73.1% in adults with obesity.
Boehringer and Zealand highlighted MRI substudy data showing up to 34% visceral fat and 63.1% liver fat reduction, lean mass ≤10.8% of tissue change, alongside continued 19% GI discontinuations.
The European Commission approved Sanofi’s subcutaneous Sarclisa with an on-body injector across all existing EU IV multiple myeloma indications; Phase 3 IRAKLIA supported non-inferior ORR and far fewer systemic reactions, with reviews ongoing elsewhere.
Market reaction
ZEAL fell as much as ~26% (about -24% at last check) after the full dataset, cited as the weakest Stoxx 600 performer; shares were also described as down nearly 50% YTD.
Our view
We expect investors to keep bifurcating obesity exposure—rewarding agents that broaden outcomes or improve delivery while discounting programs with commercially limiting GI tolerability. Next key swing factors are whether survodutide’s discontinuation/vomiting profile can be framed as manageable, and how retatrutide’s reported MACE signal is adjudicated across doses.
What could change our view
Evidence emerges that survodutide GI discontinuations are controllable, reversing bearish readthrough.
Retatrutide safety review links MACE to treatment, undermining comorbidity upside narrative.
Tickers: $ZEAL, $LLY, $SNY
Recalls
3 events
FDA- and CPSC-linked recalls hit Target baby wipes plus Haleon Gas‑X softgels and Vornado heaters sold at Costco, sharpening compliance and return-execution focus.
Latest Development
Target voluntarily recalled select Up & Up fragrance-free and cucumber-scented baby wipes after FDA testing detected Burkholderia bacteria; multiple pack sizes sold nationwide in stores and online are eligible for refunds.
Haleon voluntarily recalled four lots of Gas‑X Extra Strength Softgels 125 mg after a packaging-machine leak may have introduced diluted propylene glycol-based coolant; affected 72- and 120-count bottles expire Nov. 30, 2028.
CPSC recalled over 255,000 Vornado SRTH tower heaters over overheating and fire risk tied to fan-blade detachment; 32 overheating reports include 8 fires and one smoke inhalation case, spanning Costco and other retailers.
Our view
These recalls stay limited to identified lots/models and remain primarily execution and reputational issues for named retailers and Haleon rather than a broader category disruption. Monitor for any adverse-event reports or an expanded recall scope that would raise liability exposure and operational costs.
What could change our view
FDA/CPSC actions broaden scope beyond current lots or additional products are implicated.
Confirmed serious infections, injuries, or fires drive litigation and higher recall costs.
Tickers: $TGT, $HLN, $COST
Macro & Policy Digest
Trump publicly urges new Fed chair Warsh to cut rates before June FOMC as inflation expectations rise and independence concerns lift volatility risk.
Latest Development
• Trump said there is no reason to raise rates and called for cuts toward 1% or lower ahead of Warsh’s June 16–17 debut FOMC, with fed funds currently 3.50%–3.75%.
Our view
The Fed holds policy around 3.50%–3.75% into June, with inflation the binding constraint despite louder political pressure and higher independence-risk premium in rates. May CPI (expected 4.2%) and any chair-led shift at the June 16–17 meeting are the next catalysts.
What could change our view
May CPI prints well below 4.2%, reopening a near-term cut path.
Explicit FOMC signals that independence is compromised, repricing front-end rates sharply.
Tickers: $TLT
Trump executive order tightens customs enforcement, raising penalty floors and broker liability as DHS prepares tougher Importer-of-Record requirements within 180 days.
Latest Development
• A June 3 EO directs CBP/DHS within 90 days to set at least a 50% penalty-mitigation floor, add liquidated-damages minimums, and remove mitigation for repeat customs violators.
Our view
This is a compliance- and cost-tightening shift that incrementally pressures import-heavy industrial, transport, and consumer supply chains rather than altering trade flows immediately. Watch the 90-day mitigation-rule rewrite and 180-day IOR overhaul details for how broadly higher bonds, disclosures, and broker due-diligence standards are applied.
What could change our view
Implementing rules prove narrower, delaying meaningful penalty and IOR changes.
CBP escalates enforcement faster than expected, triggering material disruptions and fines.
Tickers: $XLI
CMS tightens Medicaid medically frail exemptions ahead of January work requirement, raising verification burdens and operational complexity for states and managed care.
Latest Development
CMS guidance narrows “medically frail” exemptions into a two-step impairment test ahead of January’s 80-hours-per-month Medicaid work requirement, leaving non-uniform assessment standards and forcing early adopters like Nebraska to conform.
Our view
Higher administrative friction and tighter exemptions reduce Medicaid retention versus prior state planning, creating incremental uncertainty for Medicaid-heavy managed care names. Watch for follow-on CMS clarifications and state implementation choices that determine how consistently and quickly the new standard is applied.
What could change our view
CMS issues uniform assessment standards that materially ease exemption verification burdens.
Implementation delays or state workarounds reduce near-term enrollment and operational effects.
Tickers: $CNC
Company Events
Airlines face renewed margin pressure as IATA halves 2026 profit outlook on jet-fuel shock and American trims select domestic capacity.
Latest Development
IATA cut its 2026 global airline net profit forecast to $23B from $45B, citing jet-fuel prices seen ~70% higher YoY and an added ~$100B industry fuel bill.
American Airlines will temporarily suspend six domestic routes in August–September, with one report citing an Aug. 5–Oct. 5 window; impacted passengers can rebook or take refunds.
Our view
We expect the group’s near-term tape to stay fuel-cost dominated, with earnings risk skewed lower unless carriers demonstrate faster fare and capacity actions to offset jet-fuel inflation. Watch jet-fuel price trajectory and evidence of effective pass-through via fares and targeted capacity trimming into late summer schedules.
What could change our view
Jet-fuel prices fall materially, easing cost pressure and supporting margin recovery.
Demand proves more price-inelastic, enabling broader fare increases without volume hit.
Tickers: $JETS, $AAL
Abel’s first big Berkshire move pairs a $6.8B Taylor Morrison buy with a $10B Alphabet private placement backing AI infrastructure.
Latest Development
Berkshire agreed to acquire Taylor Morrison for $6.8B to combine site-built homebuilding operations, while committing $10B to Alphabet via a private placement split between Class A and C shares.
Our view
Both transactions advance toward completion, reinforcing a more active capital-allocation posture under Greg Abel without materially changing Berkshire’s near-term risk profile. Key monitor is disclosure of definitive acquisition terms and any regulatory or closing conditions that could delay or reshape the Taylor Morrison integration plan.
What could change our view
Regulatory, board, or documentation hurdles prevent the Taylor Morrison deal from closing.
Alphabet placement terms or timing shift, reducing perceived support for AI buildout.
Tickers: $TMHC
Italian bank consolidation heats up as Intesa launches an unsolicited €30.6B bid for MPS, challenging Banco BPM’s merger-of-equals interest.
Latest Development
Intesa offered 16 new shares per 10 MPS plus €1 cash, implying €10.09 per share (12.5% premium); Banco BPM signaled interest in a merger of equals, with Credit Agricole open to value-creation options.
Our view
Expect elevated M&A optionality across Italian banks to remain a near-term support for EU bank sentiment, with outcomes hinging on bid escalation and asset carve-outs. Watch for disclosed timetables, regulatory conditions, and shareholder-vote requirements, plus whether the Unipol branch/MPS-brand transfer framework is accepted.
What could change our view
Regulators or shareholders block the transaction or impose onerous divestment conditions.
Competing bidder terms materially change valuation, undermining read-through for sector consolidation.
Tickers: $EUFN
Go deeper -
For intraday developments, follow our Midday posts.
For the close, the wrap, and next-day trade ideas, read the Evening Memo.
For deeper work, Forward Valuation covers multi-week single-name setups (paid subscribers only).
Deep Dive is where we publish our full thematic research for paid subscribers.
Informational only; not investment advice. Sources deemed reliable.